Onyx Pharmaceuticals

Acquired by Amgen

Onyx is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer.  The company is focused on developing novel medicines that target key molecular pathways, such as Nexavar® tablets, Kyprolis® for injection and Blincyto® process.